Education only · provider review required
SS-31 (Elamipretide) · Mitochondrial research context
An educational overview of what researchers have and have not established about SS-31. Education only · provider review required.
Medically reviewed by Bernard Garcia, MD
What it is
SS-31, also referred to in the literature as elamipretide, is a synthetic mitochondria-targeting tetrapeptide. Research articles describe it as a member of the Szeto-Schiller (SS) family of peptides, characterized by an alternating aromatic-cationic structure that is reported to concentrate within the inner mitochondrial membrane.
Scientific interest in SS-31 centers on the mitochondrion as a subcellular target. The literature discusses it in the context of cellular bioenergetics research rather than as an established treatment, and this page reflects that framing without describing any therapeutic use.
How it works
Mechanistically, SS-31 is described in the literature as associating with cardiolipin, a phospholipid concentrated in the inner mitochondrial membrane. Researchers discuss this interaction in relation to the organization of the electron transport chain and the efficiency of cellular energy production.
By binding cardiolipin, SS-31 is characterized in research as potentially influencing mitochondrial membrane structure and reducing certain reactive oxygen species under experimental conditions. Whether and how these laboratory observations translate to any clinical context has not been established here and remains a subject for qualified researchers and licensed providers to evaluate.
Research status
| Research area | Status |
|---|---|
| Mitochondrial membrane interaction | Studied in relation to cardiolipin binding in laboratory research |
| Cellular bioenergetics | Discussed in the context of electron transport chain organization |
| Oxidative stress models | Examined for effects on reactive oxygen species under experimental conditions |
| Safety and long-term outcomes | Not established; requires evaluation by qualified researchers and licensed providers |
Status reflects published research context only and is not a statement of safety, efficacy, or suitability for any person.
Is it legal?
Regulatory status varies by country and can change. In the United States, SS-31 / elamipretide has been studied in investigational settings, and its availability and permitted uses should be confirmed against current official sources rather than assumed. Nothing on this page is a claim about approval, safety, or suitability for any purpose.
This material is provided for education only. A licensed provider determines appropriateness after a confidential intake. Education only · provider review required.
Frequently asked questions
What is SS-31?
It is a synthetic mitochondria-targeting tetrapeptide, also called elamipretide, studied in cellular energy research. This page is educational and not a recommendation for use.
What does 'mitochondria-targeting' mean here?
The literature describes SS-31 as concentrating within the inner mitochondrial membrane and associating with the phospholipid cardiolipin. The significance of this is a matter for qualified researchers and licensed providers.
Is SS-31 appropriate for me?
This page cannot answer that. A licensed provider determines appropriateness only after a confidential intake and review of your individual circumstances.
Where do the research claims come from?
The research summary on this page links to a primary source record for this compound, such as its public NIH database entry, where applicable. This page is educational only and is not a substitute for advice from a licensed provider.
Next step
Next step: a 3-minute confidential intake, reviewed by a licensed provider. No treatment is promised or implied.
Free · about 10 minutes · reviewed by a licensed physician
General education · Not medical advice · Provider approval required